Brief: Alzchem Confirms FY Confirmed
30/07/2025 05:58
July 30 (Reuters) - Alzchem Group AG ACT1.DE: EQS-NEWS: ALZCHEM GROUP AG CONTINUES GROWTH TRAJECTORY IN THE FIRST HALF OF 2025 – FORECAST FOR THE FULL YEAR CONFIRMED ALZCHEM GROUP AG - H1 EBITDA RISES BY 9% TO EUR 56.5 MILLION ALZCHEM GROUP AG - H1 SALES SLIGHTLY EXCEED PREVIOUS YEAR AT EUR 287.6 MILLION ALZCHEM GROUP AG - H1 CONSOLIDATED NET INCOME ROSE BY 14% FROM EUR 26.7 MILLION TO EUR 30.5 MILLIO ALZCHEM GROUP AG - H1 CONSOLIDATED NET INCOME ROSE BY 14% FROM EUR 26.7 MILLION TO EUR 30.5 MILLION ALZCHEM GROUP AG - H1 EBITDA MARGIN OF 19.6% (PREVIOUS YEAR: 18.1%) Source text: ID:nEQ3w15HHa Further company coverage: ACT1.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on AlzChem AG
See all newsGermany's Alzchem jumps 6.5% after defence contractor CSG secures 20% stake
Brief: Alzchem Group AG Further Increase In Shareholding By Czechoslovak Group
Creamino Is Now Approved In EU For Use In Turkey Nutrition
Germany's Alzchem Group Q1 EBITDA, sales rise on specialty chemicals focus
Brief: Alzchem Confirms 2026 Forecast For Further Sales And EBITDA Growth